Syneron Medical has received the US Food and Drug Administration (FDA) approval for its new elos Plus multi-platform device. The new elos Plus device utilizes the company's proprietary elos technology of optical energy and bi-polar ...
Tags: FDA, elos Plus multi-platform device, medical technology
The Health Canada has approved Syneron Medical's new elos Plus multi-platform device, designed for use in aesthetic applications. The device, which uses the company's proprietary elos technology of optical energy and bi-polar ...